000			01908nam a2200217Ia 4500
999			_c156935 _d156935
020			_a9789052010649
040			_cCUS
082			_a346.048 _bGOV/I
245		0	_aIntellectual property, public policy and international trade/ _cedited by Inge Govaere and Hanns Ullrich
260			_aNew York: _bP.I.E. Peter Lang, _c2007.
300			_a232 p. : _bill. ; _c22 cm.
440			_a(College of Europe studies), _v6 _923462
505			_aNurturing a transnational system of innovation / Jerome H. Reichman -- Shaping a fair international IPR-regime in a globalized world. Some parameters for public policy / Thomas Dreier -- From huts to labs and back again. Stimulating the production of biodiversity-based drugs while ensuring an equitable sharing of the benefits flowing thereby / Gustavo Ghidini and Emanuela Arezzo -- Regulating protection, preservation and technology transfer of biodiversity-based drugs. Patents, contracts and local working requirements under the microscope / Geertrui Van Overwalle -- International price discrimination and market segmentation for patented pharmaceuticals in the EU : a social welfare analysis / Klaus Stegemann -- International price discrimination and market segmentation for patented pharmaceuticals in the EU. A social welfare analysis : a comment / Carsten Fink -- The Doha Waiver and its effects on the nature of the TRIPS system and on competition law. The impact of human rights / Thomas Cottier -- The so-called "waiver compromise" of Doha and Hong Kong. About contested concepts of the nature of the international intellectual property system : a comment / Christine Godt.
650			_aTechnological innovations--Law and legislation _923463
650			_aForeign trade regulation
650			_aIntellectual property
650			_aDrugs--Patents _923464
700			_aGovaere, Inge, ed. _923465
700			_aUllrich, Hanns, ed. _923466
942			_cWB16 _02